EXHIBIT 1018 
`
`Coalition For Affordable Drugs XI LLC
`Exhibit 1018
`Coalition For Affordable Drugs XI LLC v Insys Pharma, Inc.
`IPR2015-01797
`
`

`
`Notice of Allowability
`
`Application No.
`13/895,111
`ggggjtnfgndsman
`
`App|icant(s)
`KOTTAYIL ET AL.
`fgiynit
`;‘,'{;,<§‘,;it,',""°"*°'*°
`No
`
`-- The MAILING DA TE of this communication appears on the cover sheet with the correspondence address--
`All claims being allowable, PROSECUTION ON THE MERITS IS (OR REMAINS) CLOSED in this application.
`If not included
`herewith (or previously mailed), a Notice of Allowance (PTOL—85) or other appropriate communication will be mailed in due course. THIS
`NOTICE OF ALLOWABILITY IS NOT A GRANT OF PATENT RIGHTS. This application is subject to withdrawal from issue at the initiative
`of the Office or upon petition by the applicant. See 37 CFR 1.313 and MPEP 1308.
`
`1. IXI This communication is responsive to the amendment dated 4/15/14.
`
`I: A declaration(s)/affidavit(s) under 37 CFR 1.130(b) was/were filed on
`
`2. I:I An election was made by the applicant in response to a restriction requirement set forth during the interview on
`requirement and election have been incorporated into this action.
`
`; the restriction
`
`3. E The allowed cIaim(s) is/are L6. As a result of the allowed cIaim(s), you may be eligible to benefit from the Patent Prosecution
`Highway program at a participating intellectual property office for the corresponding application. For more information, please see
`mt’ :/'./vwvw.L.=s ‘to. ov/ atents/init events/' h/'index.'s' or send an inquiry to PPHfeedback@us;;to.qov.
`
`4. I:I Acknowledgment is made of a claim for foreign priority under 35 U.S.C. § 119(a)—(d) or (f).
`
`Certified copies:
`
`a) [I All
`
`b) I] Some
`
`*c) I:I None of the:
`
`1. D Certified copies of the priority documents have been received.
`
`2. D Certified copies of the priority documents have been received in Application No. j
`
`3. El Copies of the certified copies of the priority documents have been received in this national stage application from the
`
`International Bureau (PCT Rule 17.2(a)).
`
`* Certified copies not received:
`
`Applicant has THREE MONTHS FROM THE “MAILING DATE” of this communication to file a reply complying with the requirements
`noted below. Failure to timely comply will result in ABANDONMENT of this application.
`THIS THREE-MONTH PERIOD IS NOT EXTENDABLE.
`
`5. I:I CORRECTED DRAWINGS (as “replacement sheets”) must be submitted.
`
`I:I
`
`including changes required by the attached Examiner’s Amendment / Comment or in the Office action of
`Paper No./Mail Date
`Identifying indicia such as the application number (see 37 CFR 1.84(c)) should be written on the drawings in the front (not the back) of
`each sheet. Replacement sheet(s) should be labeled as such in the header according to 37 CFR 1.121(d).
`
`6. El DEPOSIT OF and/or INFORMATION about the deposit of BIOLOGICAL MATERIAL must be submitted. Note the
`attached Examiner’s comment regarding REQUIREMENT FOR THE DEPOSIT OF BIOLOGICAL MATERIAL.
`
`Attachment(s)
`1. El Notice of References Cited (PTO—892)
`
`2. IX Information Disclosure Statements (PTO/SB/08),
`Paper No./Mail Date 7/22/13
`3. El Examiner’s Comment Regarding Requirement for Deposit
`of Biological Material
`4. I:I Interview Summary (PTO—413),
`Paper No./Mail Date
`
`5. IX] Examiner’s Amendment/Comment
`
`6. El Examiner’s Statement of Reasons for Allowance
`
`7. El Other
`
`.
`
`Primary Examiner, Art Unit 1647 U.S. Patent and Trademark Office
`
`/Robert Landsman/
`
`PTOL-37 (Rev. 08-13)
`
`Notice of Allowability
`
`Part of Paper No./Mail Date 20140423
`
`

`
`Application/Control Number: 13/895,111
`
`Art Unit: 1647
`
`Page 2
`
`EXAMINER’S COMMENT
`
`The present application is being examined under the pre-AIA first to invent provisions.
`
`The first six pages of the Form PTO-1449 dated 7/22/13 is being provided herewith. The last
`
`(7th) page is not being provided as it was mailed with the Office Action dated 11/21/13.
`
`Advisory information
`Any inquiry concerning this communication or earlier communications from the examiner should
`be directed to Robert Landsman, Ph.D. whose telephone number is (571) 272-0888. The examiner can
`normally be reached M—F 8 AM — 6 PM (eastern).
`If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor,
`Joanne Hama, can be reached at 571-272-2911. The fax phone number for the organization where this
`application or proceeding is assigned is 571-273-8300.
`Information regarding the status of an application may be obtained from the Patent Application
`Information Retrieval (PAIR) system. Status information for published applications may be obtained from
`either Private PAIR or Public PAIR. Status information for unpublished applications is available through
`Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto. gov. Should
`you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC)
`at 866-217-9197 (toll-free).
`
`/Robert Landsman/
`
`Primary Examiner, Art Unit 1647